1. Introduction {#sec1-molecules-24-02835}
===============

As one of the most important heterocyclic compounds, coumarin was widely found in nature products \[[@B1-molecules-24-02835],[@B2-molecules-24-02835]\], and several synthetic coumarins \[[@B3-molecules-24-02835]\] with a variety of pharmacophoric groups at C-3, C-4, and C-7 positions have been intensively screened for various biological activities like AChE inhibitors \[[@B4-molecules-24-02835],[@B5-molecules-24-02835],[@B6-molecules-24-02835]\], anticancer \[[@B7-molecules-24-02835],[@B8-molecules-24-02835],[@B9-molecules-24-02835]\], anticoagulant \[[@B10-molecules-24-02835],[@B11-molecules-24-02835]\], anti-HIV \[[@B12-molecules-24-02835],[@B13-molecules-24-02835],[@B14-molecules-24-02835]\], antitubercular \[[@B15-molecules-24-02835],[@B16-molecules-24-02835]\], anti-inflammatory \[[@B17-molecules-24-02835],[@B18-molecules-24-02835]\], antioxidant \[[@B19-molecules-24-02835]\], antibacterial \[[@B20-molecules-24-02835]\], antihypertensive \[[@B21-molecules-24-02835]\], anticonvulsant \[[@B22-molecules-24-02835]\], antifungal \[[@B23-molecules-24-02835]\], and antihyperglycemic \[[@B24-molecules-24-02835]\]. A recent literature survey suggests quite a few coumarin derivatives have been patented for their biological properties ([Figure 1](#molecules-24-02835-f001){ref-type="fig"}). Besides the high biological activity, coumarin is also considered to be a functional material \[[@B25-molecules-24-02835],[@B26-molecules-24-02835]\] such as receptors \[[@B27-molecules-24-02835],[@B28-molecules-24-02835],[@B29-molecules-24-02835]\], signaling units in sensors and biosensors, as well as in advanced photophysical systems \[[@B30-molecules-24-02835],[@B31-molecules-24-02835]\].

Among various nitrogen-containing heterocyclic compounds, pyrazolo\[3,4-*b*\]pyridine is recognized as important drug molecular skeleton in recent years due to a wide varieties of biological activities ([Figure 2](#molecules-24-02835-f002){ref-type="fig"}), such as antimicrobial \[[@B32-molecules-24-02835],[@B33-molecules-24-02835]\], anti-inflammatory \[[@B34-molecules-24-02835],[@B35-molecules-24-02835]\], anti-proliferative \[[@B36-molecules-24-02835],[@B37-molecules-24-02835]\], and many other \[[@B38-molecules-24-02835],[@B39-molecules-24-02835]\] important effects.

Therefore, development and introduction of a convenient, efficient method for the synthesis of coumarin-fused pyrazolo\[3,4-*b*\]pyridine is highly desirable for their immense pharmacological potential. As a part of our research on the synthesis of novel functionalized heterocyclic derivatives \[[@B40-molecules-24-02835],[@B41-molecules-24-02835],[@B42-molecules-24-02835],[@B43-molecules-24-02835],[@B44-molecules-24-02835],[@B45-molecules-24-02835],[@B46-molecules-24-02835]\], in the current paper, we report a novel three-component domino reaction for the synthesis of functionalized coumarin-fused pyrazolo\[3,4-*b*\]pyridine derivatives using silica sulfuric acid as the catalyst. It worth mentioning that participation of alcohols in construction of coumarin derivatives is described for the first time.

2. Results and Discussion {#sec2-molecules-24-02835}
=========================

In the early literature reports of our group \[[@B44-molecules-24-02835]\], the coumarino\[4,3-d\]pyrazolo\[3,4-b\]pyridine derivative (**3a**) was synthesized by the reaction of 3-acylcoumarin (**1a**) with 5-aminopyrazole (**2a**) catalyzed by silica sulfuric acid (SSA) in EtOH at 90 °C for 20 min under microwave irradiation ([Scheme 1](#molecules-24-02835-sch001){ref-type="scheme"}).

According to our previously reported synthetic procedure, we speculate that the coumarin derivative **6a** could be obtained from the 2-butyryl-3*H*-benzo\[*f*\]chromen-3-one (**4a**) and 3-methyl-1-phenyl-1*H*-pyrazol-5-amine (**2a**) used as the starting materials. However, product **6a** was not available as expect ([Scheme 2](#molecules-24-02835-sch002){ref-type="scheme"}-1). Considering the steric hindrance effect of the reaction, when ethanol and ethylene glycol (EG) as mixed solvent (volume ratio of EG/EtOH = 1:1) was added to the reaction, and further increasing the temperature (120 °C), a new product **7a** formed unexpectedly ([Scheme 2](#molecules-24-02835-sch002){ref-type="scheme"}-2), which was identified by ^1^H-NMR, ^13^C-NMR, HRMS analysis. Moreover, we also obtained the single crystal of **7a** suitable for X-ray analysis ([Figure 3](#molecules-24-02835-f003){ref-type="fig"}) \[[@B47-molecules-24-02835]\]. To our surprise, the solvent ethanol also participated in this reaction and a novel coumarin derivative was constructed.

In order to achieve the optimal conditions of three-component reaction, a series of catalysts, solvents, and temperature were screened, as shown in [Table 1](#molecules-24-02835-t001){ref-type="table"}. Some other acid catalysts such as *p*-TsOH, HClO~3~S, H~2~SO~4~, SiO~2~-H~2~SO~4~ ([Table 1](#molecules-24-02835-t001){ref-type="table"}. entries 1, 3--5) and base catalysts such as K~2~CO~3~, NaOH, Cs~2~CO~3~ ([Table 1](#molecules-24-02835-t001){ref-type="table"}, entries 6--8) were tested. However, none of them gave better results, lead to the identification of SSA as the most effective catalyst ([Table 1](#molecules-24-02835-t001){ref-type="table"}. entry 2). To further increase the yield of desired product **7a**, different solvents were evaluated. The results revealed that EtOH and EG as mixed solvents greatly improved the transformation, in control to EtOH, PEG, glycerol, and DMF as a single solvent ([Table 1](#molecules-24-02835-t001){ref-type="table"}, entries 2, 9--12). When the volume ratio of EG/EtOH = 3:1, the yield of **7a** could further increase to 68% ([Table 1](#molecules-24-02835-t001){ref-type="table"}, entry 15). Much to our delight, we observed that increasing of the temperature to 140 °C resulted in affording **7a** in 84% yield ([Table 1](#molecules-24-02835-t001){ref-type="table"}, entry 20).

With optimal conditions in hand, the corresponding novel coumarin-fused pyrazolo\[3,4-*b*\]pyridine derivatives **7** were synthesized ([Scheme 3](#molecules-24-02835-sch003){ref-type="scheme"}).

As illustrated in [Scheme 3](#molecules-24-02835-sch003){ref-type="scheme"}, the substrate scope of the transformation was examined using arylbenzo\[f\]chromen-3-one **4**, enaminone **2**, and alkyl alcohol **5** as staring materials. Notably, electronic effects had an important impact on this reaction. When the substituent R^3^ was electron-donating group, such as Me, the desired products could not be obtained at all (**7e**, **7f**).

To further expand the scope of substrates, aryl alcohols (**8**) instead of alkyl alcohols (**5**) were also tested. It was found that aryl alcohols were well tolerated under the optimal reaction conditions, the corresponding products were afforded in moderate to good yields. When substituent R^3^ was electron-withdrawing groups (Ph), the yields were good and no more than 1 h cost ([Table 2](#molecules-24-02835-t002){ref-type="table"}, entries 1--19). However, the substituents R^3^ was electron-donating groups (CH~3~) ([Table 2](#molecules-24-02835-t002){ref-type="table"}, entries 20--22), the yields were lower and the reaction time was longer. Unfortunately, When R^3^ and R^4^ was electron rich group, such as Me, the reaction could not proceed successfully ([Table 2](#molecules-24-02835-t002){ref-type="table"}, entry 23).

To gain insight into the mechanism of this one-spot three-component reaction process, some additional experiments were performed. When benzaldehyde (**10**) was added to the reaction instead of phenylmethanol (**8a**) under standard conditions, 73% yield of desired product (**9a**) could be obtained, and reaction time reduced from 1 h to 15 min ([Scheme 4](#molecules-24-02835-sch004){ref-type="scheme"}A), and when butyraldehyde (**11**) was added to the reaction 50% yield of desired product (**7c**) could be obtained ([Scheme 4](#molecules-24-02835-sch004){ref-type="scheme"}B). The reaction did not proceed successfully without SSA catalyzed. Just phenylmethanol (**8a**) was heated to 140 °C, directly with the catalyst of SSA, benzaldehyde (**10**) and benzoic acid (**12**) could be detected by GC-MS ([Scheme 4](#molecules-24-02835-sch004){ref-type="scheme"}C). We speculated that the benzaldehyde was most likely the key intermediate in this protocol.

Herein, we propose the following mechanism for the reaction ([Scheme 5](#molecules-24-02835-sch005){ref-type="scheme"}). SSA catalyzed alkyl alcohol **5** to afford the corresponding aldehyde, then the intermediate **A** is formed by means of a Knoevenagel condensation of aldehyde and arylbenzo\[*f*\]chromen-3-one (**4**). The intermediate **A** is activated by SSA, which subsequently undergoes Michael addition with enaminone (**2**) via attack of the nucleophilic C-4 of the intermediate **A** to give intermediate **B**, which transformed to more-stable intermediate **C**. Then, intermediate **C** tautomerizes to intermediate **D**, which undergoes intramolecular nucleophilic addition to form intermediate **E**. In the last step, loss of H~2~O affords the desired product.

3. Conclusions {#sec3-molecules-24-02835}
==============

In conclusion, we have developed a protocol for the facile synthesis of various potentially biologically active coumarin-fused pyrazolo\[3,4-*b*\]pyridine derivatives, based on a novel three-component domino reaction under microwave irradiation. Using this method, coumarin derivatives could be rapidly constructed in moderate-to-good yields with short reaction time. Further study to deeply understand the reaction mechanism is currently underway in our lab.

4. Experimental Section {#sec4-molecules-24-02835}
=======================

4.1. General {#sec4dot1-molecules-24-02835}
------------

All reagents were purchased from commercial suppliers (Aladdin, Shanghai, China) and used without further purification. Microwave irradiation was carried out with Initiator 2.5 Microwave Synthesizers from Biotage, Uppsala, Sweden. The reaction temperatures were measured by infrared detector during microwave heating. Melting points are uncorrected. IR spectra were recorded on a Tensor 27 spectrometer (Bruker Corp., Karlsruhe, Germany) in KBr with absorptions in cm^−1^. ^1^H-NMR (400 MHz) and ^13^C-NMR (75 MHz or 100 MHz) spectra were recorded on a Varian Inova-400 MHz or Varian Inova-300 MHz (Varian, CA, America) in CDCl~3~, DMSO-*d*~6~ or CF~3~COOD as solution. *J* values are in hertz. Chemical shifts are expressed in parts per million downfield from interal standard TMS. High-resolution mass spectra (HRMS) for all the compounds were determined on Bruker MicrOTOF-QII mass spectrometer (Bruker Corp., Karlsruhe, Germany) with ESI resource. X-ray diffraction analysis was recorded on a Smart-1000 diffractometer (PANalytical B.V., Holland).

4.2. General Procedure for the Synthesis of Products 4 Are Represented as Follows {#sec4dot2-molecules-24-02835}
---------------------------------------------------------------------------------

Typically, 2-hydroxy-1-naphthaldehyde (5 mmol), ethyl 3-oxopentanoate or ethyl 3-oxohexanoate or ethyl acetoacetate (5 mmol) and piperidine (0.5 mmol) were introduced in a 20 mL vial with ethanol (10 mL) as solution. Subsequently, the reaction vial was closed and then prestirred for 10 s. The mixture was irradiated at 90 °C for 10 min. After the completion, the reaction mixture was then cooled to room temperature and concentrated in vacuo to remove the solvent. The residue was then washed with water, filtered, dried, and the precipitate was purified by recrystallization from 95% EtOH to give the products of **4**. The analytical data for represent compounds are shown below. ^1^H-NMR and ^13^C-NMR spectra of compounds **4** in [Supplementary Materials](#app1-molecules-24-02835){ref-type="app"}.

### 4.2.1. *2-Butyryl-3H-benzo\[f\]chromen-3-one* (**4a**) {#sec4dot2dot1-molecules-24-02835}

Yellow solid; yield 89%; m.p.: 127--129 °C; IR (KBr): *ν* 1734, 1626, 1557, 1513, 1383, 1109, 864 cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz) *δ* (ppm): 9.21 (s, 1H, ArH), 8.91 (s, 1H, ArH), 8.06 (d, *J* = 8.8 Hz, 1H, ArH), 7.83 (d, *J* = 8.8 Hz, 1H, ArH), 7.57--7.56 (m, 1H, ArH), 7.20 (d, *J* = 9.2 Hz, 1H, ArH), 7.12 (dd, *J*~1~ = 8.8 Hz, *J*~2~ = 2.0 Hz, 1H, ArH), 3.00 (t, *J* = 7.2 Hz, 2H, CH~2~), 1.63--1.58 (m, 2H, CH~2~), 0.93 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13^C-NMR (100 MHz, DMSO-*d*~6~) *δ* (ppm): 197.5, 159.1, 158.9, 156.4, 142.8, 136.6, 132.1, 131.5, 124.6, 121.9, 118.6, 113.0, 111.4, 104.8, 43.9, 17.3, 14.1;

### 4.2.2. *2-Butyryl-9-methoxy-3H-benzo\[f\]chromen-3-one* (**4b**) {#sec4dot2dot2-molecules-24-02835}

Yellow solid, yield 88%; m.p.: 125--128 °C; IR (KBr) *ν*: 1730, 1667, 1601, 1556, 1513, 1386, 1365, 1196, 948, 836 cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz) *δ* (ppm): 9.01 (s, 1H, ArH), 7.86 (d, *J* = 8.8 Hz, 1H, ArH), 7.68 (d, *J* = 8.8 Hz, 1H, ArH), 7.40 (s, 1H, ArH), 7.14 (t, *J* = 8.4 Hz, 2H, ArH), 3.94 (s, 3H, CH~3~O), 3.12 (t, *J* = 8.4 Hz, 2H, CH~2~); 1.76--1.70 (m, 2H, CH~2~), 1.00 (t, *J* = 8.4 Hz, 3H, CH~3~); ^13^C-NMR (100 MHz, CDCl~3~) *δ* (ppm): 197.6, 159.9, 158.7, 156.0, 142.5, 135.3, 131.2, 130.2, 124.7, 121.1, 117.9, 113.1, 111.4, 100.7, 55.5, 44.0, 16.9, 13.3.

### 4.2.3. *2-Propionyl-3H-benzo\[f\]chromen-3-one* (**4c**) {#sec4dot2dot3-molecules-24-02835}

Yellow solid, yield 87%; m.p.: 134--136 °C; IR (KBr): *ν* 1732, 1662, 1601, 1556, 1524, 1387, 1365, 1196, 945, 823 cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz) *δ* (ppm): 9.15 (s, 1H, ArH), 8.74 (s, 1H, ArH), 7.90 (d, *J* = 8.8 Hz, 1H, ArH), 7.66 (d, *J* = 8.8 Hz, 1H, ArH), 7.41--7.40 (m, 1H, ArH), 7.04 (d, *J* = 8.8 Hz, 1H, ArH), 6.95 (dd, *J*~1~ = 8.8 Hz, *J*~2~ = 2.0 Hz, 1H, ArH), 3.14--3.08 (m, 2H, CH~2~), 1.08 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13^C-NMR (100 MHz, CDCl~3~) *δ* (ppm): 198.4, 159.9, 159.4, 156.7, 143.3, 135.9, 131.9, 130.8, 125.3, 121.8, 118.7, 113.7, 112.1, 102.0, 35.2, 10.7.

### 4.2.4. *9-Methoxy-2-propionyl-3H-benzo\[f\]chromen-3-one* (**4d**) {#sec4dot2dot4-molecules-24-02835}

Yellow solid, yield 87%; m.p.: 125--128 °C; IR (KBr): *ν* 1730, 1667, 1601, 1556, 1513, 1386, 1365, 1196, 948, 836 cm^−1^; ^1^H-NMR (DMSO-*d*~6~, 400 MHz) *δ* (ppm): 9.19 (s, 1H, ArH), 8.14 (d, *J =* 9.2 Hz, 1H, ArH), 7.90 (d, *J =* 9.2 Hz, 1H, ArH), 7.79 (s, 1H, ArH), 7.32 (t, *J =* 8.8 Hz, 1H, ArH), 7.21 (dd, *J~1~ =* 8.8 Hz, *J~2~ =* 2.0 Hz, 1H, ArH), 3.98 (s, 3H, CH~3~O), 3.10--3.05 (m, 2H, CH~2~), 1.09 (t, *J =* 7.2 Hz, 3H, CH~3~); ^13^C-NMR (100 MHz, DMSO-*d*~6~) *δ* (ppm): 198.7, 160.4, 158.8, 156.1, 143.0, 136.2, 131.9, 131.2, 125.4, 122.8, 118.6, 113.9, 112.1, 102.4, 56.2, 35.4, 8.4.

### 4.2.5. *2-Acetyl-3H-benzo\[f\]chromen-3-one* (**4e**) {#sec4dot2dot5-molecules-24-02835}

Yellow solid, yield 88%; m.p.: 189--190 °C \[[@B48-molecules-24-02835]\]; IR (KBr): *ν* 2959, 1696, 1622, 1562, 1384, 1227, 1206, 857 cm^−1^.

4.3. General Procedure for the Synthesis of Products ***7*** and ***9*** Are Represented as Follows {#sec4dot3-molecules-24-02835}
---------------------------------------------------------------------------------------------------

Typically, benzo\[*f*\]chromen-3-one **4** (0.5 mmol), enaminone **2** (0.5 mmol), alkyl alcohol **5** (1.0 mL) or aryl alcohols **8** (1.0 mL) and SSA (0.25 g) were introduced in a 5 mL vial with ethylene glycol (3 mL) as solution. Subsequently, the reaction vial was closed and then prestirred for 10 s. The mixture was irradiated at 140 °C. The reaction was monitored by TLC. After the completion, the reaction mixture was then cooled to room temperature and diluted with cold water (30 mL), and extracted with CH~2~Cl~2~ (3 × 30 mL). The extracts were washed with water (3 × 50 mL) and dried over anhydrous Na~2~SO~4~. After evaporation of the solvent under reduced pressure, the precipitate was collected and purified by recrystallization from 95% EtOH or by flash column chromatography (petroleum ether:ethyl acetate = 8:1) to give the products **7** or **9**. The analytical data for represent compounds are shown below. ^1^H-NMR and ^13^C-NMR spectra of compounds **7** and **9** in [Supplementary Materials](#app1-molecules-24-02835){ref-type="app"}.

### 4.3.1. *2-(5-Ethyl-3,4-dimethyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**7a**) {#sec4dot3dot1-molecules-24-02835}

White solid, m.p.: 258--260 °C; IR (KBr, cm^−1^) *ν*: 2960, 1722, 1629, 1572, 1507, 1415, 1387, 1315, 1290, 1248, 1211, 1096, 989, 906, 815, 787, 713, 691, 605; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.07 (s, 1H, ArH), 8.58 (d, *J* = 8.0 Hz, 1H, ArH), 8.23 (t, *J* = 8.0 Hz, 3H, ArH), 8.08 (d, *J* = 8.0 Hz, 1H, ArH), 7.69--7.61 (m, 3H, ArH), 7.44 (t, *J* = 8.0 Hz, 2H, ArH), 7.20 (t, *J* = 7.2 Hz, 1H, ArH), 2.78--2.66 (m, 8H, 2 × CH~3~ + CH~2~), 1.05 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 156.0, 148.8, 146.2, 145.4, 140.5, 139.1, 135.6, 134.1, 132.6, 132.0, 131.2, 130.8, 130.2, 129.4, 128.5, 126.5, 122.3, 121.3, 116.7, 116.2, 22.7, 17.0, 14.3, 13.4; HRMS: *m*/*z* cacld. for C~29~H~24~N~3~O~2~ \[M + H\]^+^ 446.1869, Found 446.1853.

### 4.3.2. *2-(4,5-Diethyl-3-methyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**7b**) {#sec4dot3dot2-molecules-24-02835}

White solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2974, 1719, 1688, 1656, 1628, 1596, 1628, 1571, 1546, 1506, 1413, 1357, 1204, 1071, 909, 817, 752, 694, 676, 589; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.16 (s, 1H, ArH), 8.66 (d, *J* = 8.4 Hz, 1H, ArH), 8.29 (d, *J* = 9.2 Hz, 1H, ArH), 8.21 (d, *J* = 7.6 Hz, 2H, ArH), 8.11 (d, *J* = 8.0 Hz, 1H, ArH), 7.73--7.63 (m, 3H, ArH), 7.47 (t, *J* = 8.0 Hz, 2H, ArH), 7.23 (t, *J* = 7.6 Hz, 1H, ArH), 3.51--3.48 (m, 2H, CH~2~), 3.17--3.14 (m, 2H, CH~2~), 2.79 (s, 3H, CH~3~), 1.35 (t, *J* = 7.2 Hz, 3H, CH~3~), 1.09 (t, *J* = 7.6 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 160.2, 154.3, 153.8, 149.4, 148.1, 142.4, 139.6, 134.1, 130.5, 130.3, 129.6, 129.0, 128.3, 126.8, 125.7, 123.2, 120.5, 117.2, 115.9, 113.5, 100.0, 22.2, 21.6, 16.6, 16.2, 15.5; HRMS: *m*/*z* cacld. for C~30~H~25~N~3~O~2~ (M)^+^ 459.1947, Found 459.1946.

### 4.3.3. *2-(5-Ethyl-3-methyl-1-phenyl-4-propyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**7c**) {#sec4dot3dot3-molecules-24-02835}

White solid, m.p.: 242--245 °C; IR (KBr, cm^−1^) *ν*: 2974, 2880, 2703, 2545, 1789, 1722, 1665, 1573, 1503, 1439, 1414, 1389, 1359, 1320, 1288, 1248, 1217, 1155, 1091, 915, 858, 813, 792, 745, 695, 641, 610; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.14 (s, 1H, ArH), 8.63 (d, *J* = 8.8 Hz, 1H, ArH), 8.26 (d, *J* = 8.8 Hz, 1H, ArH), 8.22 (d, *J* = 8.0 Hz, 2H, ArH), 8.09 (d, *J* = 8.0 Hz, 1H, ArH), 7.70--7.63 (m, 3H, ArH), 7.46 (t, *J* = 7.6 Hz, 2H, ArH), 7.22 (t, *J* = 7.6 Hz, 1H, ArH), 3.07--3.06 (m, 2H, CH~2~), 2.76--2.73 (m, 5H, CH~3~ + CH~2~), 1.72--1.69 (m, 2H, CH~2~), 1.13 (s, 3H, CH~3~), 1.07 (s, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 165.7, 155.9, 148.1, 146.2, 145.9, 140.8, 139.1, 135.0, 134.1, 132.6, 131.9, 131.2, 130.7, 130.2, 129.3, 128.5, 126.5, 121.6, 121.3, 116.3, 33.4, 26.2, 22.2, 14.5, 13.7; HRMS: *m*/*z* cacld. for C~31~H~28~N~3~O~2~ \[M + H\]^+^ 474.2182, Found 474.2210.

### 4.3.4. *2-(5-Ethyl-3,4-dimethyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-9-methoxy-3H-benzo\[f\]chromen-3-one* (**7d**) {#sec4dot3dot4-molecules-24-02835}

White solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2975, 2026, 1795, 1728, 1628, 1574, 1509, 1230, 1091, 989, 917, 840, 794, 751, 686, 610; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.21 (s, 1H, ArH), 8.24--8.17 (m, 3H, ArH), 8.01--7.96 (m, 2H, ArH), 7.50--7.45 (m, 3H, ArH), 7.27--7.21 (m, 2H, ArH), 3.90 (s, 3H, OCH~3~), 2.80--2.79 (m, 8H, CH~2~ + 2 × CH~3~), 1.07 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 160.3, 160.1, 154.4, 154.0, 149.0, 143.1, 142.4, 140.0, 139.7, 133.8, 131.4, 131.0, 129.5, 127.5, 125.6, 125.5, 120.3, 118.7, 116.9, 114.3, 102.6, 56.3, 22.4, 16.1, 15.4, 15.0; HRMS: *m*/*z* cacld. for C~30~H~26~N~3~O~3~ \[M + H\]^+^ 476.1974, Found 476.1980.

### 4.3.5. *2-(5-Ethyl-3-methyl-1,4-diphenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9a**) {#sec4dot3dot5-molecules-24-02835}

Yellow solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 3032, 2978, 2888, 2763, 1725, 1049, 958, 815, 756, 699, 679, 588; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 10.16 (s, 1H, ArH), 9.15--9.14 (m, 2H, ArH), 8.88--8.87 (m, 1H, ArH), 8.65--8.64 (m, 1H, ArH), 8.59--8.55 (m, 4H, ArH), 8.51--8.47 (m, 6H, ArH), 8.38--8.37 (m, 2H, ArH), 3.77--3.76 (m, 2H, CH~2~), 3.05 (s, 3H, CH~3~), 1.91 (s, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 163.7, 156.1, 149.4, 146.8, 146.4, 140.8, 139.1, 135.8, 134.3, 132.8, 132.6, 132.0, 131.6, 131.2, 130.8, 130.2, 129.9, 129.5, 128.5, 127.8, 126.5, 121.9, 121.4, 116.8, 116.3, 113.6, 22.9, 14.3, 12.5; HRMS: *m*/*z* cacld. for C~34~H~26~N~3~O~2~ \[M + H\]^+^ 508.2025, Found 508.2025.

### 4.3.6. *2-(5-Ethyl-3-methyl-1-phenyl-4-(p-tolyl)-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9b**) {#sec4dot3dot6-molecules-24-02835}

Yellow solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2968, 1972, 1779, 1572, 1505, 1413, 1360, 1207, 1088, 961, 898, 806, 758, 728, 690, 642; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 10.13 (s, 1H, ArH), 9.15--9.09 (m, 2H, ArH), 8.87--8.84 (m, 1H, ArH), 8.63--8.60 (m, 1H, ArH), 8.54--8.40 (m, 9H, ArH), 8.25--8.24 (m, 2H, ArH), 3.76--3.74 (m, 2H, CH~2~), 3.37 (s, 3H, CH~3~), 3.06 (s, 3H, CH~3~), 1.88--1.87 (m, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 162.8, 155.1, 148.6, 145.6, 145.4, 142.0, 139.8, 138.2, 135.0, 133.3, 131.7, 131.1, 130.3, 129.9, 129.6, 129.3, 128.7, 128.5, 127.6, 126.9, 125.6, 121.0, 120.4, 115.9, 115.4, 112.7, 21.9, 19.5, 13.4, 11.7; HRMS: *m*/*z* cacld. for C~35~H~28~N~3~O~2~ \[M + H\]^+^ 522.2182, Found 522.2180.

### 4.3.7. *2-(5-Ethyl-4-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9c**) {#sec4dot3dot7-molecules-24-02835}

Yellow solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2967, 1711, 1597, 1571, 1505, 1412, 1286, 1249, 1211, 1048, 982, 897, 849, 806, 758, 690, 641, 587; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 9.29 (s, 1H, ArH), 8.28--8.23 (m, 2H, ArH), 7.99 (d, *J* = 8.4 Hz, 1H, ArH), 7.76 (t, *J* = 7.6 Hz, 1H, ArH), 7.69--7.56 (m, 7H, ArH), 7.50 (d, *J* = 8.4 Hz, 2H, ArH), 7.35 (d, *J* = 8.4 Hz, 2H, ArH), 4.06 (s, 3H, OCH~3~), 2.93--2.88 (m, 2H, CH~2~), 2.23 (s, 3H, CH~3~), 1.02 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 162.9, 160.9, 160.5, 155.2, 148.4, 145.8, 145.7, 140.0, 138.3, 135.3, 133.5, 131.8, 131.2, 130.4, 130.0, 129.4, 129.2, 128.7, 127.7, 125.8, 125.3, 121.3, 120.6, 116.0, 115.5, 114.9, 112.8, 55.1, 22.1, 13.4, 12.0; HRMS: *m*/*z* cacld. for C~35~H~28~N~3~O~3~ \[M + H\]^+^ 538.2131, Found 538.2111.

### 4.3.8. *2-(5-Ethyl-4-(3-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9d**) {#sec4dot3dot8-molecules-24-02835}

Yellow solid, m.p.: \>300 °C;.IR (KBr, cm^−1^) *ν*: 2965, 2023, 1785, 1712, 1573, 1504, 1382, 1357, 1285, 1158, 1136, 1046, 782, 759, 712, 689, 588; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.23 (s, 1H, ArH), 8.66 (d, *J* = 8.4 Hz, 1H, ArH), 8.29--8.23 (m, 3H, ArH), 8.10 (d, *J* = 8.0 Hz, 1H, ArH), 7.73--7.62 (m, 3H, ArH), 7.54--7.47 (m, 3H, ArH), 7.25 (t, *J* = 7.6 Hz, 1H, ArH), 7.14--7.12 (m, 1H, ArH), 7.03--7.01 (m, 2H, ArH), 3.84 (s, 3H, OCH~3~), 2.58--2.56 (m, 2H, CH~2~), 1.96 (s, 3H, CH~3~), 0.89 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 160.2, 159.6, 154.2, 153.9, 148.7, 145.3, 142.9, 140.1, 139.6, 137.3, 134.3, 130.5, 130.4, 130.1, 129.6, 129.5, 129.4, 129.0, 127.8, 126.8, 125.9, 123.1, 121.4, 120.6, 117.2, 115.8, 114.6, 113.5, 55.8, 22.5, 16.0, 14.2; HRMS: *m*/*z* cacld. for C~35~H~27~N~3~O~3~ (M)^+^ 537.2052, Found 537.2053.

### 4.3.9. *2-(4-(4-Bromophenyl)-5-ethyl-3-methyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9e**) {#sec4dot3dot9-molecules-24-02835}

Yellow solid, m.p.: \>300 °C;.IR (KBr, cm^−1^) *ν*: 2968, 2032, 1775, 1721, 1574, 1385, 1357, 1285, 1166, 1047, 782, 759, 712, 681, 588; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 10.19 (s, 1H, ArH), 8.57--8.53 (m, 2H, ArH), 8.43 (d, *J* = 9.2 Hz, 1H, ArH), 8.06 (d, *J* = 8.0 Hz, 1H, ArH), 7.86 (t, *J* = 7.6 Hz, 1H, ArH), 7.78--7.23 (m, 10H, ArH), 2.79 (s, 2H, CH~2~), 2.54(s, 3H, CH~3~), 1.35 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 165.7, 159.3, 157.7, 152.3, 151.4, 144.7, 141.6, 138.9, 134.8, 132.3, 131.0, 129.7, 126.7, 125.2, 121.4, 118.1, 113.1, 111.4, 111.3, 109.6, 107.5, 21.9, 17.0, 14.6; HRMS: *m*/*z* cacld. for C~34~H~24~BrN~3~O~2~ (M)^+^ 585.1052, Found 585.1057.

### 4.3.10. *2-(5-Ethyl-3-methyl-1-phenyl-4-(pyridin-4-yl)-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9f**): {#sec4dot3dot10-molecules-24-02835}

Yellow solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2965, 1972, 1783, 1573, 1505, 1413, 1362, 1089, 961, 898, 805, 758, 693, 642; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 10.09 (s, 1H, ArH), 9.11--9.05 (m, 2H, ArH), 8.80 (d, *J* = 8.0 Hz, 1H, ArH), 8.60--8.35 (m, 10H, ArH), 8.21--8.19 (m, 2H, ArH), 3.72--3.70 (m, 2H, CH~2~), 3.01 (s, 3H, CH~3~), 1.83 (t, *J* = 6.8 Hz, 3H, CH~3~);^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 162.8, 155.0, 148.5, 145.5, 145.4, 142.0, 139.7, 138.1, 135.0, 133.3, 131.6, 131.0, 130.2, 129.8, 129.5, 129.2, 128.7, 128.5, 127.5, 126.8, 125.5, 121.0, 120.4, 115.8, 115.3, 112.6, 21.8, 13.3, 11.6; HRMS: *m*/*z* cacld. for C~33~H~25~N~4~O~2~ \[M + H\]^+^ 509.1978, Found 509.1963.

### 4.3.11. *2-(5-Ethyl-4-(furan-2-yl)-3-methyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9g**): {#sec4dot3dot11-molecules-24-02835}

Yellow solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2966, 1720, 1629, 1566, 1412, 1383, 1264, 1084, 959, 852, 797, 766, 724, 691, 640, 617; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 9.24 (s, 1H, ArH), 8.21 (d, *J* = 9.2 Hz, 1H, ArH), 7.95 (d, *J* = 8.8 Hz, 1H, ArH), 7.65--7.63 (m, 2H, ArH), 7.62--7.55 (m, 6H, ArH), 7.46 (d, *J* = 9.2 Hz, 1H, ArH), 7.39 (m, 3H, ArH), 2.93--2.87 (m, 2H, CH~2~), 2.21 (s, 3H, CH~3~), 1.03 (t, *J* = 7.6 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 163.0, 160.2, 156.0, 148.7, 145.7, 142.1, 140.0, 137.9, 135.2, 133.5, 131.9, 131.5, 130.7, 130.5, 129.8, 129.0, 127.1, 126.9, 125.8, 121.2, 118.0, 115.4, 113.7, 112.2, 22.1, 13.6, 11.8; HRMS: *m*/*z* cacld. for C~32~H~24~N~3~O~3~ \[M + H\]^+^ 498.1818, Found 498.1831.

### 4.3.12. *2-(5-Ethyl-3-methyl-1,4-diphenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-9-methoxy-3H-benzo\[f\]chromen-3-one* (**9h**) {#sec4dot3dot12-molecules-24-02835}

White solid, m.p.: 248--250 °C; IR (KBr, cm^−1^) *ν*: 2968, 1724, 1631, 1573, 1507, 1434, 1414, 1384, 1354, 1281, 1241, 1135, 1105, 980, 960, 905, 827, 789, 758, 705, 692, 636; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.32 (s, 1H, ArH), 8.24 (d, *J* = 8.0 Hz, 2H, ArH), 8.17 (d, *J* = 9.2 Hz, 1H, ArH), 8.00--7.97 (m, 2H, ArH), 7.61--7.57 (m, 3H, ArH), 7.51--7.46 (m, 5H, ArH), 7.27--7.24 (m, 2H, ArH), 3.91 (s, 3H, OCH~3~), 2.54--2.53 (m, 2H, CH~2~), 1.89 (s, 3H, CH~3~), 0.86 (t, *J* = 7.6 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 160.3, 160.2, 154.5, 154.4, 148.7, 145.5, 142.8, 140.6, 139.5, 135.9, 134.0, 131.5, 131.0, 130.5, 129.6, 129.1, 129.0, 128.9, 127.0, 125.9, 125.7, 120.6, 118.7, 115.8, 114.3, 112.8, 102.7, 56.3, 22.5, 15.8, 14.2; HRMS: *m*/*z* cacld. for C~35~H~28~N~3~O~3~ \[M + H\]^+^ 538.2131, Found 538.2122.

### 4.3.13. *2-(5-Ethyl-3-methyl-1-phenyl-4-(p-tolyl)-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-9-methoxy-3H-benzo\[f\]chromen-3-one* (**9i**) {#sec4dot3dot13-molecules-24-02835}

Yellow solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2966, 1720, 1628, 1570, 1417, 1383, 1264, 1084, 959, 904, 832, 796, 761, 725, 691, 678, 640, 602; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 9.24 (s, 1H, ArH), 8.20 (d, *J* = 9.2 Hz, 1H, ArH), 7.95 (d, *J* = 8.8 Hz, 1H, ArH), 7.65--7.54 (m, 8H, ArH), 7.46 (d, *J* = 9.2 Hz, 1H, ArH), 7.39 (d, *J* = 7.6 Hz, 3H, ArH), 4.04 (s, 3H, OCH~3~), 2.92--2.87 (m, 2H, CH~2~), 2.52 (s, 3H, CH~3~), 2.20 (s, 3H, CH~3~), 1.02 (t, *J* = 7.6 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 162.9, 160.1, 155.9, 148.6, 145.6, 145.5, 142.0, 139.8, 137.8, 135.1, 133.4, 131.8, 131.4, 130.6, 130.4, 129.6, 128.9, 127.0, 126.8, 125.7, 121.1, 117.9, 115.3, 113.6, 112.1, 55.3, 22.0, 19.6, 13.5, 11.8; HRMS: *m*/*z* cacld. for C~36~H~30~N~3~O~3~ \[M + H\]^+^ 552.2287, Found 552.2246.

### 4.3.14. *2-(5-Ethyl-4-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-9-methoxy-3H-benzo\[f\]chromen-3-one* (**9j**) {#sec4dot3dot14-molecules-24-02835}

White solid, m.p.: 256--258 °C; IR (KBr, cm^−1^) *ν*: 2965, 2145, 1735, 1717, 1629, 1572, 1463, 1381, 1286, 1227, 1077, 960, 887, 884, 805, 691, 604, 567; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.33 (s, 1H, ArH), 8.23 (d, *J* = 8.0 Hz, 2H, ArH), 8.19 (d, *J* = 8.8 Hz, 1H, ArH), 8.01--7.99 (m, 2H, ArH), 7.52--7.48 (m, 3H, ArH), 7.39--7.38 (m, 2H, ArH), 7.28--7.25 (m, 2H, ArH), 7.16 (d, *J* = 8.8 Hz, 2H, ArH), 3.92 (s, 3H, OCH~3~), 2.87 (s, 3H, OCH~3~), 2.56--2.55 (m, 2H, CH~2~), 1.95 (s, 3H, CH~3~), 0.87 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 160.3, 160.2, 159.7, 154.6, 154.4, 148.8, 145.5, 142.9, 140.6, 139.6, 134.0, 131.5, 131.0, 130.9, 130.4, 129.7, 127.8, 127.1, 125.9, 125.7, 120.6, 118.8, 116.2, 114.3, 112.8, 102.7, 56.4, 55.7, 22.5, 15.8, 14.5; HRMS: *m*/*z* cacld. for C~36~H~30~N~3~O~4~ \[M + H\]^+^ 568.2236, Found 568.2248.

### 4.3.15. *2-(3,5-Dimethyl-1,4-diphenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9k**) {#sec4dot3dot15-molecules-24-02835}

Yellow solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2934, 2173, 1710, 1598, 1572, 1438, 1278, 965, 909, 820, 791, 692, 651, 633, 585; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 9.33 (s, 1H, ArH), 8.29--8.24 (m, 2H, ArH), 8.00--7.97 (m, 1H, ArH), 7.72--7.61 (m, 11H, ArH), 7.48--7.47 (m, 2H, ArH), 2.42 (s, 3H, CH~3~), 2.22 (s, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 155.3, 148.3, 146.2, 145.8, 139.9, 138.5, 133.5, 132.4, 131.8, 131.1, 130.8, 130.4, 130.0, 129.4, 129.3, 129.0, 128.7, 127.7, 126.9, 125.7, 120.6, 120.4, 115.9, 115.5, 112.9, 14.5, 12.0; HRMS: *m*/*z* cacld. for C~33~H~24~N~3~O~2~ \[M + H\]^+^ 494.1869, Found 494.1887.

### 4.3.16. *2-(3,5-Dimethyl-1-phenyl-4-(p-tolyl)-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9l**) {#sec4dot3dot16-molecules-24-02835}

Yellow solid, m.p.: 286--290 °C; IR (KBr, cm^−1^) *ν*: 3078, 2187, 1719, 1626, 1606, 1575, 1507, 1447, 1380, 1212, 1093, 963, 813, 790, 741, 685; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 9.35 (s, 1H, ArH), 8.31 (d, *J* = 9.2 Hz, 1H, ArH), 8.27 (d, *J* = 7.6 Hz, 1H, ArH), 8.02 (d, *J* = 8.4 Hz, 1H, ArH), 7.79 (t, *J* = 7.2 Hz, 1H, ArH), 7.72--7.57 (m, 9H, ArH), 7.39 (d, *J* = 7.6 Hz, 2H, ArH), 2.55 (s, 3H, CH~3~), 2.46 (s, 3H, CH~3~), 2.29 (s, 3H, CH~3~); ^13^C-NMR (75 MHz, CF~3~COOD) *δ* (ppm): 154.3, 147.5, 145.2, 144.5, 141.3, 138.9, 137.5, 132.5, 130.8, 130.2, 129.4, 129.0, 128.8, 128.4, 128.3, 128.1, 127.7, 126.7, 126.0, 124.7, 119.6, 119.5, 114.9, 114.4, 18.6, 14.0, 10.9; HRMS: *m*/*z* cacld. for C~34~H~26~N~3~O~2~ \[M + H\]^+^ 508.2025, Found 508.2020.

### 4.3.17. *2-(4-(4-Methoxyphenyl)-3,5-dimethyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo \[f\]chromen-3-one* (**9m**) {#sec4dot3dot17-molecules-24-02835}

White solid, m.p.: 258--260 °C; IR (KBr, cm^−1^) *ν*: 2904, 2342, 1735, 1631, 1574, 1427, 1367, 1240, 1200, 1158, 1103, 1061, 849, 818, 759, 712, 668, 589; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.20 (s, 1H, ArH), 8.66 (d, *J* = 8.4 Hz, 1H, ArH), 8.28 (t, *J* = 7.6 Hz,3H, ArH), 8.11 (d, *J* = 8.0 Hz, 1H, ArH), 7.75--7.63 (m, 3H, ArH), 7.50 (t, *J* = 8.0 Hz, 2H, ArH), 7.37 (d, *J* = 8.4 Hz, 2H, ArH), 7.26 (t, *J* = 7.2 Hz, 1H, ArH), 7.16 (d, *J* = 8.4 Hz, 2H, ArH), 3.87 (s, 3H, OCH~3~), 2.13 (s, 3H, CH~3~), 2.02 (s, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 159.8, 159.6, 154.2, 154.0, 149.0, 145.3, 142.7, 140.3, 139.6, 134.3, 130.6, 130.5, 129.6 129.5, 128.1, 126.7, 125.8, 124.9, 123.1, 120.6, 117.1, 115.9, 114.4, 113.6, 55.7, 16.3, 14.7; HRMS: *m*/*z* cacld. for C~34~H~26~N~3~O~3~ \[M + H\]^+^ 524.1974, Found 524.1978.

### 4.3.18. *2-(4-(3-Methoxyphenyl)-3,5-dimethyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9n**) {#sec4dot3dot18-molecules-24-02835}

White solid, m.p.: 260--263 °C; IR (KBr, cm^−1^) *ν*: 2970, 2372, 1718, 1573, 1505, 1410, 1362, 1279, 1239, 1142, 1054, 1019, 988, 970, 877, 815, 786, 744, 714, 670, 586; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.19 (s, 1H, ArH), 8.66 (d, *J* = 8.4 Hz, 1H, ArH), 8.29--8.25 (m, 3H, ArH), 8.10 (d, *J* = 8.0 Hz, 1H, ArH), 7.75--7.63 (m, 3H, ArH), 7.52--7.48 (m, 3H, ArH), 7.25 (t, *J* = 7.6 Hz, 1H, ArH), 7.13--7.11 (m, 1H, ArH), 7.00--6.98 (m, 2H, ArH), 3.84 (s, 3H, OCH~3~), 2.13 (s, 3H, CH~3~), 2.00 (s, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 159.7, 159.6, 154.3, 154.0, 148.9, 145.2, 142.7, 140.4, 139.6, 137.6, 134.3, 130.5, 130.3, 129.6, 129.5, 129.4, 129.0, 128.1, 126.8, 125.9, 124.5, 123.1, 121.3, 120.6, 117.1, 115.5, 114.7, 114.6, 113.6, 55.8, 16.2, 14.4; HRMS: *m*/*z* cacld. for C~34~H~26~N~3~O~3~ \[M + H\]^+^ 524.1974, Found 524.1978.

### 4.3.19. *2-(3,5-Dimethyl-1-phenyl-4-(p-tolyl)-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-9-methoxy-3H-benzo\[f\]chromen-3-one* (**9o**) {#sec4dot3dot19-molecules-24-02835}

Yellow solid, m.p.: 288--290 °C; IR (KBr, cm^−1^) *ν*: 2929, 1718, 1631, 1600, 1346, 1239, 1204, 1173, 1149, 1125, 1019, 852, 827, 795, 749, 690, 643, 606; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 9.28 (s, 1H, ArH), 8.22 (d, *J* = 8.8 Hz, 1H, ArH), 7.96 (d, *J* = 8.8 Hz, 1H, ArH), 7.65--7.62 (m, 6H, ArH), 7.56--7.54 (m, 2H, ArH), 7.46 (d, *J* = 8.8 Hz, 1H, ArH), 7.41--7.35 (m, 3H, ArH), 4.04 (s, 3H, OCH~3~), 2.52 (s, 3H, CH~3~), 2.44 (s, 3H, CH~3~), 2.26 (s, 3H, CH~3~); ^13C-NMR\ (75\ MHz,\ CF^~3~COOD) *δ* (ppm): 159.0, 158.9, 155.0, 147.4, 145.2, 144.4, 141.2, 138.8, 137.0, 132.4, 130.7, 130.4, 129.6, 129.4, 128.8, 128.2, 128.1, 126.0, 125.8, 124.6, 119.4, 116.6, 115.2, 114.1, 112.5, 54.2, 18.5, 14.0, 10.9; HRMS: *m*/*z* cacld. for C~35~H~28~N~3~O~3~ \[M + H\]^+^ 538.2131, Found 538.2130.

### 4.3.20. *9-Methoxy-2-(4-(4-methoxyphenyl)-3,5-dimethyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9p**) {#sec4dot3dot20-molecules-24-02835}

Yellow solid, m.p.: 287--289 °C; IR (KBr, cm^−1^) *ν*: 1716, 1630, 1611, 1571, 1513, 1464, 1385, 1246, 1107, 1033, 960, 832, 795, 754, 691; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 9.29 (s, 1H, ArH), 8.23 (d, *J* = 8.8 Hz, 1H, ArH), 7.56 (d, *J* = 8.8 Hz, 1H, ArH), 7.65--7.63 (m, 6H, ArH), 7.48--7.42 (m, 3H, ArH), 7.39--7.35 (m, 3H, ArH), 4.07--4.05 (m, 6H, 2 × OCH~3~), 2.46 (s, 3H, CH~3~), 2.30 (s, 3H, CH~3~); ^13C-NMR\ (75\ MHz,\ CF^~3~COOD) *δ* (ppm): 159.6, 159.0, 155.0, 147.2, 145.1, 144.6, 138.9, 137.0, 132.4, 130.7, 130.4, 129.6, 129.3, 128.3, 128.1, 125.8, 124.6, 116.6, 114.0, 112.5, 54.3, 54.0, 14.0, 11.1; HRMS: *m*/*z* cacld. for C~35~H~28~N~3~O~4~ \[M + H\]^+^ 554.2080, Found 554.2093.

### 4.3.21. *2-(3,5-Dimethyl-1,4-diphenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-9-methoxy-3H-benzo\[f\]chromen-3-one* (**9q**) {#sec4dot3dot21-molecules-24-02835}

Yellow solid, m.p.: 252--254 °C; IR (KBr, cm^−1^) *ν*: 2961, 1725, 1629, 1582, 1557, 1435, 1397, 1335, 1290, 1250, 1219, 1196, 999, 906, 819, 797, 753, 695, 625; ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ* (ppm): 9.29 (s, 1H, ArH), 8.28--8.26 (m, 2H, ArH), 8.17 (d, *J* = 9.2 Hz, 1H, ArH), 8.01--7.98 (m, 2H, ArH), 7.62--7.57 (m, 3H, ArH), 7.52--7.43 (m, 5H, ArH), 7.28--7.25 (m, 2H, ArH), 3.92 (s, 3H, OCH~3~), 2.11 (s, 3H, CH~3~), 1.95 (s, 3H, CH~3~); ^13^C-NMR (75 MHz, DMSO-*d*~6~) *δ* (ppm): 160.2, 159.7, 154.6, 154.5, 148.9, 145.3, 142.6, 140.8, 139.6, 136.2, 134.0, 131.5, 131.1, 129.7, 129.2, 129.1, 127.4, 125.9, 125.7, 124.5, 120.7, 118.7, 115.5, 114.3, 112.9, 102.8, 56.3, 16.2, 14.5; HRMS: *m*/*z* cacld. for C~34~H~26~N~3~O~3~ \[M + H\]^+^ 524.1974, Found 524.1988.

### 4.3.22. *2-(3-Methyl-1,4-diphenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9r**) {#sec4dot3dot22-molecules-24-02835}

Yellow solid, m.p.: 268--270 °C; IR (KBr, cm^−1^) *ν*: 2935, 2355, 1729, 1667, 1553, 1092, 891, 818, 746, 694, 657, 631, 585; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 10.22 (s, 1H, ArH), 8.61--8.57 (m, 2H, ArH), 8.46 (d, *J* = 9.2 Hz, 1H, ArH), 8.09 (d, *J* = 8.0 Hz, 1H, ArH), 7.90 (t, *J* = 7.6 Hz, 1H, ArH), 7.82--7.76 (m, 11H, ArH), 7.70 (d, *J* = 8.8 Hz, 1H, ArH), 2.58 (s, 3H, CH~3~); ^13C-NMR\ (75\ MHz,\ CF^~3~COOD) *δ* (ppm): 163.5, 159.1, 155.0, 147.5, 145.0, 144.8, 140.3, 138.7, 132.9, 132.4, 131.1, 130.4, 130.3, 130.0, 129.8, 128.8, 128.3, 127.9, 127.4, 127.3, 122.6, 120.1, 114.3, 114.1, 113.5, 11.9; HRMS: *m*/*z* cacld. for C~32~H~22~N~3~O~2~ \[M + H\]^+^ 480.1712, Found 480.1726.

### 4.3.23. *2-(4-(4-Methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9s**) {#sec4dot3dot23-molecules-24-02835}

Yellow solid, m.p.: \>300 °C; IR (KBr, cm^−1^) *ν*: 2988, 2355, 1987, 1730, 1512, 1089, 1066, 959, 810, 809, 788, 765, 689, 654, 633, 599; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 11.03 (s, 1H, ArH), 9.43 (d, *J* = 8.4 Hz, 1H, ArH), 9.34--9.30 (m, 2H, ArH), 8.94 (d, *J* = 8.0 Hz, 1H, ArH), 8.75 (t, *J* = 7.6 Hz, 1H, ArH), 7.66--7.63 (m, 8H, ArH), 8.54 (t, *J* = 9.2 Hz, 1H, ArH), 8.23 (d, *J* = 8.8 Hz, 2H, ArH), 4.95 (s, 3H, OCH~3~), 3.50 (s, 3H, CH~3~); ^13C-NMR\ (75\ MHz,\ CF^~3~COOD) *δ* (ppm): 164.3, 159.2, 155.9, 148.2, 145.7, 145.3, 141.1, 139.8, 133.6, 131.3, 130.9, 130.6, 129.7, 128.8, 128.2, 126.6, 123.5, 120.9, 117.1, 115.1, 114.6, 55.1, 13.1; HRMS: *m*/*z* cacld. for C~33~H~24~N~3~O~3~ \[M + H\]^+^ 510.1818, Found 510.1835.

### 4.3.24. *2-(5-Ethyl-1-methyl-3,4-diphenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9t**) {#sec4dot3dot24-molecules-24-02835}

Yellow solid, m.p.: 285--288 °C; IR (KBr, cm^−1^) *ν*: 2396, 1732, 1574, 1353, 1099, 1515, 1088, 1076, 959, 810, 803, 704; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 10.26 (s, 1H, ArH), 9.25 (d, *J* = 8.8 Hz, 2H, ArH), 8.95 (d, *J* = 8.0 Hz, 1H, ArH), 8.73 (t, *J* = 7.6 Hz, 1H, ArH), 8.63 (t, *J* = 7.6 Hz, 1H, ArH), 8.46 (d, *J* = 7.6 Hz, 1H, ArH), 8.26 (t, *J* = 7.6 Hz, 1H, ArH), 8.21--8.14 (m, 3H, ArH), 8.09--8.02 (m, 4H, ArH), 7.94 (d, *J* = 7.6 Hz, 2H, ArH), 5.31 (s, 3H, CH~3~), 3.87--3.85 (m, 2H, CH~2~), 1.84 (t, *J* = 7.2 Hz, 3H, CH~3~); ^13C-NMR\ (75\ MHz,\ CF^~3~COOD) *δ* (ppm): 162.9, 155.3, 150.3, 146.0, 145.4, 140.3, 138.2, 134.3, 131.2, 131.1, 130.2, 129.9, 129.5, 129.3, 128.5, 128.3, 127.9, 127.8, 127.6, 127.1, 120.5, 119.3, 116.3, 115.5, 34.9, 21.8, 13.1; HRMS: *m*/*z* cacld. for C~34~H~26~N~3~O~2~ \[M + H\]^+^ 508.2025, Found 508.2027.

### 4.3.25. *2-(1,5-Dimethyl-3,4-diphenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-9-methoxy-3H-benzo\[f\]chromen-3-one* (**9u**) {#sec4dot3dot25-molecules-24-02835}

Yellow solid, m.p.: 260--262 °C; IR (KBr, cm^−1^) *ν*: 2697, 2551, 1783, 1708, 1628, 1567, 1511, 1469, 1441, 1387, 1330, 1218, 1149, 1017, 976, 898, 845, 796, 756, 725, 702, 601; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 10.10 (s, 1H, ArH), 9.03 (d, *J* = 9.2 Hz, 1H, ArH), 8.76 (d, *J* = 8.8 Hz, 1H, ArH), 8.66--8.65 (m, 1H, ArH), 8.28 (d, *J* = 8.8 Hz, 1H, ArH), 8.20 (d, *J* = 9.2 Hz, 1H, ArH), 8.12 (d, *J* = 7.6 Hz, 1H, ArH), 8.05--7.99 (m, 3H, ArH), 7.91--7.87 (m, 4H, ArH), 7.81 (d, *J* = 7.6 Hz, 2H, ArH), 5.18 (s, 3H, OCH~3~), 4.85 (s, 3H, CH~3~), 3.21 (s, 3H, CH~3~). ^13C-NMR\ (75\ MHz,\ CF^~3~COOD) *δ* (ppm): 162.3, 160.0, 156.0, 150.1, 146.1, 145.8, 140.3, 138.0, 131.5, 131.4, 130.6, 130.3, 129.5, 128.5, 128.3, 128.2, 128.0, 127.9, 127.2, 126.7, 117.5, 113.5, 112.2, 112.1, 103.0, 55.2, 34.8, 15.1. HRMS: *m*/*z* cacld. for C~34~H~26~N~3~O~3~ \[M + H\]^+^ 554.2080, Found 554.2093.

### 4.3.26. *9-Methoxy-2-(4-(4-methoxyphenyl)-1,5-dimethyl-3-phenyl-1H-pyrazolo\[3,4-b\]pyridin-6-yl)-3H-benzo\[f\]chromen-3-one* (**9v**) {#sec4dot3dot26-molecules-24-02835}

Yellow solid, m.p.: 240--244 °C; IR (KBr, cm^−1^) *ν*: 2932, 1720, 1624, 1608, 1564, 1512, 1463, 1383, 1353, 1289, 1249, 1208, 1173, 1025, 970, 902, 836, 801, 698, 664, 607; ^1^H-NMR (400 MHz, CF~3~COOD) *δ* (ppm): 10.15 (s, 1H, ArH), 9.09 (d, *J* = 9.2 Hz, 1H, ArH), 8.82 (d, *J* = 9.2 Hz, 1H, ArH), 8.72--8.71 (m, 1H, ArH), 8.34 (d, *J* = 9.2 Hz, 1H, ArH), 8.26 (d, *J* = 9.2 Hz, 1H, ArH), 8.17--8.13 (m, 1H, ArH), 8.02--7.95 (m, 4H, ArH), 7.89--7.87 (m, 2H, ArH), 7.69--7.66 (m, 2H, ArH), 5.23 (s, 3H, OCH~3~), 4.90 (s, 3H, OCH~3~), 4.72 (s, 3H, CH~3~), 3.31 (s, 3H, CH~3~); ^13C-NMR\ (75\ MHz,\ CF^~3~COOD) *δ* (ppm): 162.4, 160.3, 156.1, 150.0, 146.0, 145.9, 140.3, 138.1, 131.5, 130.4, 129.4, 128.7, 128.1, 128.0, 127.6, 126.8, 125.1, 117.5, 114.2, 113.5, 55.2, 55.1, 34.9, 15.1; HRMS: *m*/*z* cacld. for C~35~H~28~N~3~O~4~ \[M + H\]^+^ 524.1974, Found 524.1972.

**Sample Availability:** Samples of the compounds **4** and **7** are available from the authors.

The following are available online, Crystal date of compound **7a** \[[@B47-molecules-24-02835]\], ^1^H NMR and ^13^C NMR Spectra of all compounds and GC-MS spectra of [Scheme 4](#molecules-24-02835-sch004){ref-type="scheme"}B.

###### 

Click here for additional data file.
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![General structures of coumarin molecules possessing biological activity.](molecules-24-02835-g001){#molecules-24-02835-f001}

![Biologically active compounds having pyrazolo\[3,4-*b*\]pyridine unit.](molecules-24-02835-g002){#molecules-24-02835-f002}

![Synthesis of coumarino\[4,3-*d*\]pyrazolo\[3,4-*b*\]pyridine derivative **3a**.](molecules-24-02835-sch001){#molecules-24-02835-sch001}

![New multicomponent domino reactions.](molecules-24-02835-sch002){#molecules-24-02835-sch002}

![Crystal structure of **7a**.](molecules-24-02835-g003){#molecules-24-02835-f003}

![Synthesis of coumarin-fused pyrazolo\[3,4-*b*\]pyridine derivatives **7** **^a^**. ^a^ Reaction conditions: arylbenzo\[*f*\]chromen-3-one **4** (0.5 mmol), enaminone **2** (0.5 mmol), alkyl alcohol **5** (1.0 mL), EG (3 mL) and SSA (0.25 g), 140 °C,45 min; ^b^ Isolated yield; ^c^ 2 h.](molecules-24-02835-sch003){#molecules-24-02835-sch003}

![Preliminary mechanistic studies. (**A**) Synthesis of coumarin-fused pyrazolo\[3,4-*b*\]pyridine derivatives **9a**. (**B**) Synthesis of coumarin-fused pyrazolo\[3,4-*b*\]pyridine derivatives **7c**. (**C**) Reaction of phenylmethanol with the catalyst of SSA.](molecules-24-02835-sch004){#molecules-24-02835-sch004}

![Proposed mechanism for this reaction.](molecules-24-02835-sch005){#molecules-24-02835-sch005}

molecules-24-02835-t001_Table 1

###### 

Optimizing the reaction conditions for the synthesis of **7a** under microwave ^a^.

  Entry   Catalyst                    Solvent (*v*/*v*)     Temperature (°C)   Yield (%) ^b^
  ------- --------------------------- --------------------- ------------------ ---------------
  1       *p*-TsOH (20 mol%)          EG/EtOH=1:1           120                trace
  2       SSA (0.25 g)                EG/EtOH=1:1           120                58
  3       HClO~3~S (5 mol%)           EG/EtOH=1:1           120                36
  4       SiO~2~-H~2~SO~4~ (0.25 g)   EG/EtOH=1:1           120                \-
  5       H~2~SO~4~ (20 mol%)         EG/EtOH=1:1           120                \-
  6       K~2~CO~3~ (20 mol%)         EG/EtOH=1:1           120                \-
  7       NaOH (20 mol%)              EG/EtOH=1:1           120                \-
  8       Cs~2~CO~3~ (20 mol%)        EG/EtOH=1:1           120                \-
  9       SSA (0.25 g)                EtOH                  110                20
  10      SSA (0.25 g)                PEG/EtOH = 1:1        120                45
  11      SSA (0.25 g)                Glycerol/EtOH = 1:1   120                32
  12      SSA (0.25 g)                DMF/EtOH = 1:1        120                24
  13      SSA (0.25 g)                EG/EtOH=1:2           120                21
  14      SSA (0.25 g)                EG/EtOH = 2:1         120                55
  15      SSA (0.25 g)                EG/EtOH = 3:1         120                68
  16      SSA (0.25 g)                EG/EtOH = 4:1         120                57
  17      SSA (0.25 g)                EG/EtOH = 3:1         100                trace
  18      SSA (0.25 g)                EG/EtOH = 3:1         110                trace
  19      SSA (0.25 g)                EG/EtOH = 3:1         130                78
  20      SSA (0.25 g)                EG/EtOH = 3:1         140                84
  21      SSA (0.25 g)                EG/EtOH = 3:1         150                76

^a^ Reaction conditions: **4a** (0.5 mmol), **2a** (0.5 mmol), **5a** (1.0 mL), 45 min; ^b^ GC yield of **7a** determined using tridecane as internal standard.

molecules-24-02835-t002_Table 2

###### 

Synthesis of coumarin-fused pyrazolo\[3,4-*b*\]pyridine derivatives **9** ^a^.

![](molecules-24-02835-i001)

  Entry   Product   R^1^         R^2^     R^3^    R^4^    Ar                 Time (h)   Isolated yield (%)
  ------- --------- ------------ -------- ------- ------- ------------------ ---------- --------------------
  1       **9a**    CH~2~CH~3~   H        Ph      CH~3~   C~6~H~5~           1          69
  2       **9b**    CH~2~CH~3~   H        Ph      CH~3~   4-CH~3~C~6~H~4~    1          74
  3       **9c**    CH~2~CH~3~   H        Ph      CH~3~   4-OCH~3~C~6~H~4~   0.75       77
  4       **9d**    CH~2~CH~3~   H        Ph      CH~3~   3-OCH~3~C~6~H~4~   0.75       76
  5       **9e**    CH~2~CH~3~   H        Ph      CH~3~   4-BrC~6~H~4~       0.75       71
  6       **9f**    CH~2~CH~3~   H        Ph      CH~3~   Pyridine-4-yl      1          70
  7       **9g**    CH~2~CH~3~   H        Ph      CH~3~   Furan-2-yl         1          76
  8       **9h**    CH~2~CH~3~   OCH~3~   Ph      CH~3~   C~6~H~5~           1          62
  9       **9i**    CH~2~CH~3~   OCH~3~   Ph      CH~3~   4-CH~3~C~6~H~4~    1          70
  10      **9j**    CH~2~CH~3~   OCH~3~   Ph      CH~3~   4-OCH~3~C~6~H~4~   1          72
  11      **9k**    CH~3~        H        Ph      CH~3~   C~6~H~5~           1          68
  12      **9l**    CH~3~        H        Ph      CH~3~   4-CH~3~C~6~H~4~    1.25       70
  13      **9m**    CH~3~        H        Ph      CH~3~   4-OCH~3~C~6~H~4~   1.25       74
  14      **9n**    CH~3~        H        Ph      CH~3~   3-OCH~3~C~6~H~4~   1.25       72
  15      **9o**    CH~3~        OCH~3~   Ph      CH~3~   4-CH~3~C~6~H~4~    1.25       67
  16      **9p**    CH~3~        OCH~3~   Ph      CH~3~   4-OCH~3~C~6~H~4~   1.25       70
  17      **9q**    CH~3~        OCH~3~   Ph      CH~3~   C~6~H~5~           1.25       60
  18      **9r**    H            H        Ph      CH~3~   C~6~H~5~           1.5        56
  19      **9s**    H            H        Ph      CH~3~   4-OCH~3~C~6~H~4~   1.5        58
  20      **9t**    CH~2~CH~3~   H        CH~3~   Ph      C~6~H~5~           2          55
  21      **9u**    CH~3~        OCH~3~   CH~3~   Ph      C~6~H~5~           2          50
  22      **9v**    CH~3~        OCH~3~   CH~3~   Ph      4-OCH~3~C~6~H~4~   2          45
  23      **9w**    CH~2~CH~3~   H        CH~3~   CH~3~   4-OCH~3~C~6~H~4~   2.5        trace

^a^ Reaction conditions: arylbenzo\[*f*\]chromen-3-one **4** (0.5 mmol), enaminone **2** (0.5 mmol), aryl alcohols **8** (1.0 mL), EG (3 mL) and SSA (0.25 g), 140 °C.
